Orphan Drugs: the Conundrum- Clinical Research Trials 2015 is an event dedicated to orphan drugs.
Orphan Drugs: the Conundrum- Clinical Research Trials 2015 covers topics such as:
- Role of the FDA
- Definition of the Orphan Drug Act
- Why the varying views
- Understanding why the Orphan Drug Act has started a conundrum
- Competing in the Rare Disease Space
- Good Intentions, Bad Results
- Comparison of Rare Disease Drugs VS other drugs
- Review of drugs passed that are Orphan Drugs
- Benefits of the Orphan Drug Act VS drawbacks
Orphan Drugs: the Conundrum- Clinical Research Trials 2015 brings together attendees from:
- Director of Human Resource
- Benefit Managers
- Director of Strategy
- Director of Access
- Representatives of Purchasers
- Pharmacy Benefit Managers
- Consumer Organization Representatives
- Private Employers and Public Purchasers
- Health Care Regulators and Policy Makers
- Federal and State Government Officials
- Health Services Researchers and Academics
- Health Benefits Consultants
- Director of Accountable Care
- Chief Innovation Officers
- Director of Government Programs
- Directors of Quality Management
- Director of Medicaid Programs
- Director of Medicare Programs
- Director of Provider Relations
- Director of Network Contracting
- Pharmaceutical Executives
- Director of Reimbursement
- Director of Patient Advocacy
- Pharmaceutical Consultants
- Electronic Health Record Staff and Venders
- Pharmacy Benefit Manager